- Home
- CCEL vs FBIO Comparison
CCEL vs FBIO Comparison
Compare CCEL & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- FBIO
- Stock Information
- Founded
- CCEL 1989
- FBIO 2006
- Country
- CCEL United States
- FBIO United States
- Employees
- CCEL N/A
- FBIO N/A
- Industry
- CCEL Managed Health Care
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CCEL Health Care
- FBIO Health Care
- Exchange
- CCEL Nasdaq
- FBIO Nasdaq
- Market Cap
- CCEL 50.0M
- FBIO 48.2M
- IPO Year
- CCEL 1997
- FBIO N/A
- Fundamental
- Price
- CCEL $8.92
- FBIO $1.61
- Analyst Decision
- CCEL
- FBIO Strong Buy
- Analyst Count
- CCEL 0
- FBIO 4
- Target Price
- CCEL N/A
- FBIO $16.33
- AVG Volume (30 Days)
- CCEL 38.7K
- FBIO 593.5K
- Earning Date
- CCEL 11-19-2024
- FBIO 11-22-2024
- Dividend Yield
- CCEL 2.73%
- FBIO N/A
- EPS Growth
- CCEL N/A
- FBIO N/A
- EPS
- CCEL N/A
- FBIO N/A
- Revenue
- CCEL $31,838,476.00
- FBIO $82,624,000.00
- Revenue This Year
- CCEL $3.97
- FBIO N/A
- Revenue Next Year
- CCEL $0.91
- FBIO $81.63
- P/E Ratio
- CCEL N/A
- FBIO N/A
- Revenue Growth
- CCEL 1.95
- FBIO 31.68
- 52 Week Low
- CCEL $3.67
- FBIO $1.30
- 52 Week High
- CCEL $9.50
- FBIO $4.43
- Technical
- Relative Strength Index (RSI)
- CCEL 73.46
- FBIO 40.00
- Support Level
- CCEL $7.00
- FBIO $1.66
- Resistance Level
- CCEL $9.43
- FBIO $1.79
- Average True Range (ATR)
- CCEL 0.69
- FBIO 0.13
- MACD
- CCEL 0.25
- FBIO -0.03
- Stochastic Oscillator
- CCEL 89.95
- FBIO 12.44
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.